Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
Ethical problems in bone marrow transplantation in children
1Department of Pediatric Hematology and Oncology-G.Gaslini Children's Research Hospital, Genova-Italy.
Insights
Bone marrow transplantation (BMT) for pediatric hematological/oncological diseases presents unique ethical challenges, especially regarding donor consent. Ensuring informed consent from parents and child donors is crucial for this life-saving treatment.
Area of Science:
- Pediatric Hematology/Oncology
- Medical Ethics
- Transplantation Law
Background:
- Pediatric hematological and oncological diseases often necessitate advanced treatments like bone marrow transplantation (BMT).
- BMT is a critical therapy for incurable or treatment-resistant conditions in children.
- Ethical and legal complexities arise, particularly when a related donor is unavailable or is a minor.
Purpose of the Study:
- To explore the ethical and legal considerations surrounding pediatric bone marrow transplantation.
- To highlight the importance of informed consent in allogeneic BMT, especially involving child donors.
- To emphasize the necessary infrastructure and expertise for BMT centers.
Main Methods:
- Review of ethical and legal issues in pediatric BMT.
- Analysis of consent procedures for donors and recipients, including minors.
- Discussion of requirements for BMT units and the ethical implications of 'last hope' treatments.
Main Results:
- Allogeneic BMT requires consent from both the donor and the recipient's parents.
- When the donor is a minor, parental consent is essential, with minimal risks primarily linked to general anesthesia.
- Informed consent processes are typically reviewed and approved by institutional Ethics Committees.
Conclusions:
- Pediatric BMT involves significant ethical and legal considerations, particularly concerning consent.
- Rigorous ethical oversight and comprehensive informed consent are paramount for patient and donor safety.
- Experienced centers with robust support systems are essential for successful BMT outcomes.
Abstract:
The medical staff caring for children with hematological or oncological diseases is often faced with delicate ethical and, at times, legal problems. Although many of these are common to other branches of pediatrics where patients are children lacking decision-making capacity, others, such as bone marrow transplantation (BMT), are peculiar to this specialty. This is a vanguard treatment for a wide range of diseases that are either incurable or resistant to conventional therapies. If the patient does not have a related donor, ethical and legal problems can occur: profound emotional dilemmas arise both because of the fretful search for a donor and because of the limited period the patient can be transplanted with good expectations of success. National and International Registries are linked to all BMT Units for the identification of compatible donors with the recipient. Hospitals hosting a BMT Unit must fulfill several requirements which are crucial to guaranteeing the best results when faced with the complexity and aggressiveness of transplantation and possible complications, such as a blood bank, an infectious diseases department, a rehabilitation unit, the availability of consultants, as well as playworkers, teachers, psychologists and social workers. Any trial carried out in a Center without sufficient experience, simply pleading the concept of "last hope" is not ethical, even considering possible late effects and sequelae. For allogeneic bone marrow transplantation it is necessary to obtain both the Consent of the donor and the Consent of parents of the recipient. Often the donor is a child sibling of the patient, lacking decision-making capacity as well. Information to parents of both children must be detailed. In reality, there are practically no risks for the child donor and, if any, they are linked to the general anaesthesia. The text of the Informed Consent is usually deliberated and accepted in advance by the Ethics Committee of the Institution where the patient is followed. Voluntary donor's Consent is required at different steps: at the entry in the Registry, when typing of major histocompatibility complex, at bone marrow harvesting under general anaesthesia. In Italy, Article No. 3, Law No. 107 of May 4, 1990 allows parents or legal guardians to consent to the bone marrow donation of a minor.
Related Concept Videos
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Issues
Ethical Concerns in Healthcare:

